|
PT97888B
(pt)
|
1990-06-07 |
1998-12-31 |
Zeneca Ltd |
Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
|
|
GB9407447D0
(en)
|
1994-04-14 |
1994-06-08 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE69730980T2
(de)
|
1996-07-31 |
2006-02-23 |
Nikken Chemicals Co., Ltd. |
6-phenyltetrahydro-1,3-oxazin-2-on derivate und medizinische zusammensetzungen, die sie enthalten
|
|
EP1296958A4
(en)
|
2000-06-26 |
2004-01-28 |
Merck & Co Inc |
ANTIAGONISTS OF NMDA NR2B RECEPTORS OF IMINOPYRIMIDINE
|
|
US6610723B2
(en)
|
2001-01-29 |
2003-08-26 |
Hoffmann-La Roche Inc. |
Imidazole derivatives
|
|
DE60316542T2
(de)
|
2002-03-28 |
2008-07-03 |
Eisai R&D Management Co., Ltd. |
7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen
|
|
US7005432B2
(en)
|
2002-05-16 |
2006-02-28 |
Hoffman-La Roche Inc. |
Substituted imidazol-pyridazine derivatives
|
|
US7429609B2
(en)
|
2002-05-31 |
2008-09-30 |
Eisai R & D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
|
CA2537916A1
(en)
|
2003-09-03 |
2005-03-31 |
Neurogen Corporation |
5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
|
|
RU2006127575A
(ru)
|
2004-02-18 |
2008-03-27 |
Астразенека Аб (Se) |
Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
|
|
CA2581454A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
|
WO2006058120A1
(en)
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Bicyclic inhibitors or rho kinase
|
|
WO2007115231A2
(en)
|
2006-03-30 |
2007-10-11 |
Chemocentryx, Inc. |
Cxcr4 modulators
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
EP2167464B1
(en)
|
2007-05-25 |
2014-12-03 |
AbbVie Deutschland GmbH & Co KG |
Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
|
|
WO2009004430A1
(en)
|
2007-06-29 |
2009-01-08 |
Pfizer Inc. |
N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
|
|
JPWO2009028543A1
(ja)
|
2007-08-30 |
2010-12-02 |
武田薬品工業株式会社 |
置換ピラゾール誘導体
|
|
EP2215073A4
(en)
|
2007-10-31 |
2011-04-06 |
Merck Sharp & Dohme |
SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
|
|
MX2010009649A
(es)
|
2008-03-27 |
2010-12-17 |
Evotecv Neurosciences Gmbh |
Metodos para tratar trastornos utilizando un antagonista selectivo del subtipo nr2b de nmda.
|
|
JPWO2009157196A1
(ja)
|
2008-06-25 |
2011-12-08 |
武田薬品工業株式会社 |
アミド化合物
|
|
BRPI0917540A2
(pt)
|
2008-08-05 |
2015-11-17 |
Daiichi Sankyo Co Ltd |
composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
WO2010043396A1
(en)
|
2008-10-16 |
2010-04-22 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
KR101048448B1
(ko)
|
2008-11-21 |
2011-07-11 |
한국화학연구원 |
신규 피라졸로[4,3-ｂ]피리딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
WO2010068483A2
(en)
|
2008-11-25 |
2010-06-17 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
US8969342B2
(en)
|
2009-03-20 |
2015-03-03 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
|
US8906914B2
(en)
|
2009-08-18 |
2014-12-09 |
Janssen Pharmaceutica Nv |
Ethylene diamine modulators of fatty acid hydrolase
|
|
EP2579717A4
(en)
|
2010-06-09 |
2013-12-11 |
Merck Sharp & Dohme |
POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
|
|
DK2669270T3
(en)
|
2011-01-28 |
2018-02-26 |
Sato Pharma |
Indole-related compounds such as URAT1 inhibitors
|
|
JP2012188363A
(ja)
|
2011-03-09 |
2012-10-04 |
Dainippon Sumitomo Pharma Co Ltd |
アザベンゾイミダゾロン誘導体
|
|
MX2014001088A
(es)
|
2011-07-28 |
2015-03-19 |
Chdi Foundation Inc |
Ciertos inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas, y metodos de uso de las mismas.
|
|
PT2570415E
(pt)
*
|
2011-09-19 |
2015-11-23 |
Sanofi Sa |
N-[4-(1h-pirazolo[3,4-b]pirazin-6-il)-fenil]-sulfonamidas e a sua utilização como fármacos
|
|
WO2013060029A1
(en)
|
2011-10-28 |
2013-05-02 |
Merck Sharp & Dohme Corp |
Allosteric modulators of metabotropic glutamate receptors
|
|
WO2013130855A1
(en)
|
2012-03-02 |
2013-09-06 |
Takeda Pharmaceutical Company Limited |
Indazole derivatives
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
JP2016506962A
(ja)
|
2013-01-29 |
2016-03-07 |
ノーレックス, インコーポレイテッドNaurex, Inc. |
スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用
|
|
WO2014124651A1
(en)
|
2013-02-15 |
2014-08-21 |
Københavns Universitet |
Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
|
|
EP2970200A1
(en)
|
2013-03-13 |
2016-01-20 |
Abbvie Inc. |
Pyridine cdk9 kinase inhibitors
|
|
DK2970265T3
(en)
|
2013-03-15 |
2018-10-01 |
Plexxikon Inc |
HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
|
|
SI3010503T1
(sl)
|
2013-06-21 |
2020-07-31 |
Zenith Epigenetics Ltd. |
Novi biciklični inhibitorji bromodomene
|
|
RS58361B1
(sr)
|
2013-07-31 |
2019-03-29 |
Merck Patent Gmbh |
Piridini, pirimidini i pirazini, kao inhibitori btk i njihova upotreba
|
|
US10155727B2
(en)
|
2014-08-15 |
2018-12-18 |
Janssen Pharmaceuticals, Inc. |
Pyrazoles
|
|
WO2016025917A1
(en)
|
2014-08-15 |
2016-02-18 |
Janssen Pharmaceuticals, Inc. |
Triazoles as nr2b receptor inhibitors
|
|
US12006328B2
(en)
|
2014-11-18 |
2024-06-11 |
Emory University |
Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto
|
|
MA41803A
(fr)
|
2015-03-24 |
2018-01-30 |
Almirall Sa |
Dérivés amino-indazoles utilisés comme inhibiteurs des canaux sodiques
|
|
AU2016291158B2
(en)
|
2015-07-09 |
2020-04-30 |
Janssen Pharmaceutica Nv |
Substituted 4-azaindoles and their use as GluN2B receptor modulators
|
|
US10071988B2
(en)
|
2016-02-10 |
2018-09-11 |
Janssen Pharmaceutica Nv |
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
|
|
TW201819376A
(zh)
|
2016-10-06 |
2018-06-01 |
比利時商健生藥品公司 |
經取代之１Ｈ－咪唑並［４，５－ｂ］吡啶－２（３Ｈ）－酮及其作為ＧＬＵＮ２Ｂ受體調節劑之用途
|
|
JP7252908B2
(ja)
|
2017-06-14 |
2023-04-05 |
トレベナ・インコーポレイテッド |
Ｓ１ｐ１活性を調節するための化合物およびその使用法
|
|
US10766893B2
(en)
|
2017-12-20 |
2020-09-08 |
H. Lundbeck A/S |
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
|
|
WO2019193516A2
(en)
|
2018-04-04 |
2019-10-10 |
Janssen Pharmaceutica Nv |
Substituted pyridine and pyrimidines and their use as glun2b receptor modulators
|
|
CN110294756A
(zh)
|
2019-06-04 |
2019-10-01 |
广州市原子高科同位素医药有限公司 |
GluN2B亚基靶向型中枢神经系统正电子示踪剂及其制备
|
|
TW202112774A
(zh)
|
2019-06-14 |
2021-04-01 |
比利時商健生藥品公司 |
經取代之吡唑并－吡啶醯胺及其作為ｇｌｕｎ２ｂ受體調節劑之用途
|
|
BR112021025141A2
(pt)
|
2019-06-14 |
2022-01-25 |
Janssen Pharmaceutica Nv |
Pirazolo-piridinas heteroaromáticas substituídas e seu uso como moduladores do receptor glun2b
|
|
AU2020293642A1
(en)
|
2019-06-14 |
2022-01-20 |
Janssen Pharmaceutica Nv |
Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
|
|
CN114008052A
(zh)
|
2019-06-14 |
2022-02-01 |
詹森药业有限公司 |
取代的吡唑并-吡嗪以及它们作为GluN2B受体调节剂的用途
|
|
MX2021015511A
(es)
|
2019-06-14 |
2022-01-31 |
Janssen Pharmaceutica Nv |
Carbamatos de pirazina y sus usos como moduladores del receptor glun2b.
|
|
CA3143103A1
(en)
|
2019-06-14 |
2020-12-17 |
Janssen Pharmaceutica Nv |
Pyridine carbamates and their use as glun2b receptor modulators
|
|
SG11202113174SA
(en)
|
2019-06-14 |
2021-12-30 |
Debiopharm Int Sa |
Medicament and use thereof for treating bacterial infections involving biofilm
|
|
PY2039449A
(es)
|
2019-08-01 |
2021-12-20 |
Novartis Ag |
Inhibidortes tricíclicos de kars dependientes de akr1c3
|
|
WO2021050700A1
(en)
*
|
2019-09-13 |
2021-03-18 |
The Broad Institute, Inc. |
Cyclooxygenase-2 inhibitors and uses thereof
|
|
TW202426436A
(zh)
|
2020-06-09 |
2024-07-01 |
美商艾瑞生藥股份有限公司 |
用於治療ｂｒａｆ相關的疾病和病症之化合物
|